Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID-STEMI
NCT07641231Phase 4Not yet recruiting
- Start
- May 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 4 trial of tenecteplase in ST-segment elevation myocardial infarction (STEMI). Planned start May 2026; status: not yet recruiting.
02
Drugs
tenecteplase
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT07641231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07641231.